ConCallIQ
Go Pro

Grasim vs Bajajfinsv Q2 FY24

Side-by-side earnings comparison across financial stats, AI summaries, management guidance, risks, quotes, and accountability signals.

Grasim

neutral medium

Grasim's Q2 FY24 consolidated revenue grew 10% YoY to INR 30,221 crore, with EBITDA up 14% to INR 4,509 crore, driven by cement and financial services.

Read Grasim analysis →

Bajajfinsv

bullish high

Bajaj Finserv delivered a strong Q2 FY24 with consolidated revenue up 25% YoY to INR 26,023 crore and PAT up 24% YoY to INR 1,929 crore.

Read Bajajfinsv analysis →

Result Snapshot

Revenue₹30,221 Cr₹26,023 Cr
PAT₹3,756 Cr
EBITDA Margin38%
Sentimentneutralbullish

AI Summary

Grasim

Q2 FY24 · Diversified

Grasim's Q2 FY24 consolidated revenue grew 10% YoY to INR 30,221 crore, with EBITDA up 14% to INR 4,509 crore, driven by cement and financial services. Standalone revenue rose 4% to INR 6,442 crore, while EBITDA jumped 21% to INR 1,354 crore on higher VSF volumes (+24% YoY) and lower input costs. However, global price weakness in viscose and chloralkali persisted, and new businesses (paints, B2B e-commerce) incurred initial losses. Management guided for paints commercial launch in Q4 FY24 with three plants operational, and B2B platform Birla Pivot nearing INR 100 crore monthly run rate. Risks include sustained global demand softness in textiles and chemicals, and potential margin pressure from volatile input costs.

Guidance read
Paints commercial launch in Q4 FY24: Three plants (Panipat, Ludhiana, Cheyyar) have received consent to operate and will be operational in Q4 FY24, with product launch in the same quarter. Epoxy capacity expansion commissioning in Q3 FY24: The expanded epoxy capacity is under commissioning and expected to be operational in Q3 FY24. Renewables capacity of ~1 GW to be commissioned by Q1 FY25: Projects under implementation of about 1 GW are expected to be commissioned by next year's first quarter. Debt-to-EBITDA not to exceed ~3.5x: Even with full paints CapEx next fiscal, debt-to-EBITDA is not expected to cross about 3.5x.
Risk read
Key risks include Sustained global textile demand weakness — International brands continue to hold elevated inventories, suppressing demand for VSF and VFY; recovery timeline remains uncertain.; Volatile input costs — Caustic soda, sulfur, coal, and oil prices are volatile; recent stabilization and upticks could pressure margins.; Paints business profitability impact — Initial costs from paints business are being charged to P&L, with losses expected to persist until commercial launch and scale-up.; VFY pricing pressure from Chinese imports — Anti-dumping duty on VFY is only at DGTR recommendation stage; Chinese imports continue to pressure domestic prices due to low domestic consumption in China..
Promise ledger
Of 1 tracked promise, management 0 met, 0 close, 1 missed.

Bajajfinsv

Q2 FY24 · Diversified

Bajaj Finserv delivered a strong Q2 FY24 with consolidated revenue up 25% YoY to INR 26,023 crore and PAT up 24% YoY to INR 1,929 crore. Growth was driven by robust performance across subsidiaries: BAGIC reported a 95.3% combined ratio (lowest in 14 quarters) and 39% PAT growth, while BALIC saw NBV growth of 25% to INR 237 crore. BFL continued its momentum with 33% AUM growth and asset quality improvement. The AMC business launched with INR 5,235 crore AUM. Management guided for continued balanced growth, with BAGIC targeting sub-100% combined ratio despite near-term investment costs. Key risk: elevated claims volatility in government health and crop insurance segments could pressure underwriting profitability.

Guidance read
BAGIC combined ratio to be slightly above 100% for next few quarters: Due to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing. BALIC NBV growth expected to continue with product mix improvement: Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute. BFL to maintain long-term financial guidance metrics: BFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.
Risk read
Key risks include Government health business claims volatility — The Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.; Expense ratio normalization pressure — BAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.; Competition in crop insurance and government health — Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.; BALIC VNB margin compression from product mix shift — Higher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels..
Promise ledger
Of 2 tracked promises, management 0 met, 0 close, 2 missed.

Key Numbers

Grasim

Q2 FY24 · Diversified
VSF Volume Growth 24%
+24% YoY

Viscose staple fiber sales volume grew 24% year-over-year in Q2 FY24.

Caustic Soda Volume Growth 3%
+3% YoY

Caustic soda sales volume increased 3% year-over-year in Q2 FY24.

Epoxy Volume Growth 25%
+25% YoY

Epoxy business recorded 25% volume growth year-over-year in Q2 FY24.

Birla Pivot Quarterly Revenue INR 100 crore
N/A

B2B e-commerce platform Birla Pivot crossed INR 100 crore revenue in Q2 FY24.

Bajajfinsv

Q2 FY24 · Diversified
BAGIC Combined Ratio 95.3%
-450bps YoY

Lowest combined ratio in 14 quarters, driven by better expense ratios and reinsurance terms.

BALIC NBV INR 237 Cr
+25% YoY

New business value growth supported by improved product mix and interest rate movement.

BFL AUM INR 2,90,000 Cr
+33% YoY

Strong AUM growth driven by diversified business model and customer acquisition.

BAGIC Motor Two-Wheeler Market Share 9%
+5pp YoY

Market share doubled from ~4% two years ago, driven by OEM tie-ups and long-term policies.

Management Guidance

Grasim

Q2 FY24 · Diversified
G

Paints commercial launch in Q4 FY24

Three plants (Panipat, Ludhiana, Cheyyar) have received consent to operate and will be operational in Q4 FY24, with product launch in the same quarter.

Management guidance expansion
G

Epoxy capacity expansion commissioning in Q3 FY24

The expanded epoxy capacity is under commissioning and expected to be operational in Q3 FY24.

Management guidance expansion
G

Renewables capacity of ~1 GW to be commissioned by Q1 FY25

Projects under implementation of about 1 GW are expected to be commissioned by next year's first quarter.

Management guidance expansion
G

Debt-to-EBITDA not to exceed ~3.5x

Even with full paints CapEx next fiscal, debt-to-EBITDA is not expected to cross about 3.5x.

Management guidance other

Bajajfinsv

Q2 FY24 · Diversified
G

BAGIC combined ratio to be slightly above 100% for next few quarters

Due to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing.

Management guidance margins
G

BALIC NBV growth expected to continue with product mix improvement

Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.

Management guidance growth
G

BFL to maintain long-term financial guidance metrics

BFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.

Management guidance growth

Key Risks

Grasim

Q2 FY24 · Diversified
R

Sustained global textile demand weakness

International brands continue to hold elevated inventories, suppressing demand for VSF and VFY; recovery timeline remains uncertain.

high · management_commentary
R

Volatile input costs

Caustic soda, sulfur, coal, and oil prices are volatile; recent stabilization and upticks could pressure margins.

medium · management_commentary
R

Paints business profitability impact

Initial costs from paints business are being charged to P&L, with losses expected to persist until commercial launch and scale-up.

medium · analyst_question
R

VFY pricing pressure from Chinese imports

Anti-dumping duty on VFY is only at DGTR recommendation stage; Chinese imports continue to pressure domestic prices due to low domestic consumption in China.

medium · analyst_question

Bajajfinsv

Q2 FY24 · Diversified
R

Government health business claims volatility

The Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.

medium · management_commentary
R

Expense ratio normalization pressure

BAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.

medium · management_commentary
R

Competition in crop insurance and government health

Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.

medium · analyst_question
R

BALIC VNB margin compression from product mix shift

Higher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels.

medium · analyst_question

Key Quotes

Grasim

Q2 FY24 · Diversified
The international demand for textiles, in general, has been subdued for last 4 or 6 quarters. And the international brands have been saddled with huge inventory for multiple reasons, and they have been trying to correct their inventories by purchasing less.
Pavan Jain · CFO, Grasim Industries
We will be launching our paints in Q4, so which is in the period January, February, March. And also the three of our plants, which we have disclosed, also in the report that you have in Ludhiana, Panipat, and Cheyyar, they have got their CTO, so they are expected to become operational in Q4.
Jayant Dhobley · Business Head, Grasim Industries

Bajajfinsv

Q2 FY24 · Diversified
We have never done business in a desperate manner. We have always done business the way business should be done.
Tapan Singhel · MD and CEO, Bajaj Allianz General Insurance Company
Our purpose is to create platform to carry out health transactions for customers. It's not about acquiring customers, it's all about enabling transactions digitally.
Devang Mody · MD and CEO, Bajaj Finserv Health Limited